Filing Details
- Accession Number:
- 0001127602-12-035303
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-31 17:22:19
- Reporting Period:
- 2012-12-28
- Filing Date:
- 2012-12-31
- Accepted Time:
- 2012-12-31 17:22:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1235598 | M James Frates | Connaught House 1 Burlington Road Dublin 4 Ireland | Svp & Cfo, Alkermes Plc | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2012-12-28 | 3,752 | $18.76 | 95,959 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2012-12-31 | 3,752 | $18.33 | 92,207 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 4,000 | Indirect | By Sons |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.66 to $18.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.25 to $18.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.